Brigitte Robertson MD

Brigitte Robertson MD General Information

Biography

Dr. Brigitte Robertson served as Chief Medical Officer at Yumanity Therapeutics. She served as Chief Medical Officer at Delix. She served as the Chief Medical Officer at Euthymics Bioscience. She brings Euthymics nearly 20 years of expertise as a board-certified adult, child, and adolescent psychiatrist specializing in ADHD, with over 15 years of clinical development experience focused on ADHD treatments. Most recently, Dr. Robertson served as Global Development Strategy Team Lead, Senior Director at Shire Pharmaceuticals, where she led multiple cross-functional global development teams and was accountable for the development strategy and execution for several development programs in ADHD involving Intuniv, SPD465, and Vyvanse. Earlier, she served in senior roles at CCP Children's Hospital in San Diego, Glaxo, and Sepracor, where she gained extensive experience in early discovery and late-stage drug development across a broad array of disorders and mechanisms in psychiatry and neurology (e.g. schizophrenia, bipolar, depression, anxiety, ADHD, insomnia, PTSD and Fragile X). Dr. Robertson received an M.D. from Georgia Health Sciences University. She completed her residency in Adult Psychiatry at the University of Colorado Health Sciences Center and a subsequent Child Psychiatry fellowship and NIMH Psychopharmacology Research fellowship with an emphasis on neuroimaging at the University of California San Diego. Dr. Robertson has published several peer-reviewed articles and is active in advocacy groups for the advancement of pediatric therapeutics.